Science|Business Database: Coronavirus Funding Opportunities

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to info@sciencebusiness.net. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Mitigating the impact of COVID-19 in Bolivia

Date added: 11 May 2020

An invitation to contribute to the understanding of the COVID-19 epidemic in Bolivia and its impact on mental health, food security, the economy, and education.

Amount
Decided on a case by case basis
Agency or Funder
Universidad Autónoma Gabriel René Moreno
Eligibility (if available)

Researchers at the Universidad Autónoma Gabriel René Moreno

Foreign participation? (where known)
No

Top-up award for existing PCORI-funded Engagement Award projects

Date added: 29 Apr 2020

Funding for existing PCORI-funded projects that wish to adapt or alter their original aims to produce useful knowledge or research related to COVID-19.

Amount
Up to $150.000 (U.S.)
Agency or Funder
Patient-Centered Outcomes Research Institute (PCORI)
Eligibility (if available)

Only PCORI-funded project leads with active Engagement Award contracts are eligible

A Pandemic Response Challenge Program to meet COVID-19 related needs

Date added: 23 Apr 2020

Accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians.

Amount
C$15M
Agency or Funder
National Research Council of Canada
Eligibility (if available)

Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise.

Urgent request for expressions of interest for extraordinary financing of research projects on sars-voc-2 and covid19 disease

Date added: 23 Apr 2020

Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation.

Amount
€24M
Agency or Funder
Carlos III Health Institute

Solutions for product supplies, vaccines, treatment and diagnosis

Date added: 12 May 2020

Projects should be able to be quickly implemented and focus on increasing supplies of products to deal with the pandemic, vaccines, improving COVID-19 treatment and diagnosis, and new public health measures.

Amount
€12M
Agency or Funder
Ministry of Science and Innovation
Eligibility (if available)

Companies and technology centres

Emergency response to COVID-19 in Peru (CLOSED)

Date added: 11 May 2020

Funding for innovative and low-cost solutions focused on COVID-19 diagnosis, treatment, epidemiology, PEE, and telehealth.

Amount
Up to PEN 350,000
Agency or Funder
Fondo Nacional de Desarrollo Científico y Tecnológico, Peru
Eligibility (if available)

Public and private Peruvian institutions, non-profits, universities, and international and foreign centres based in Peru

Foreign participation? (where known)
No

Open call for proposals for the COVID-19 Google Research Credits Program

Date added: 05 May 2020

Research projects for potential treatments, techniques and datasets will be prioritised according to their impact on public health. Preference will be given to projects that plan to make their datasets publicly available and referenceable.

Amount
$5.000 (U.S.) in GCP credits. PhD awards $1,000 (U.S.)
Agency or Funder
Google
Eligibility (if available)

A commercial, nonprofit, government or academic research institution based in a country where Google Credits Program credits are approved.

Foreign participation? (where known)
Yes

Proposals invited for research into the novel coronavirus

Date added: 23 Apr 2020

A call for proposals for better understanding of diagnosis, prevention and management of the virus

Amount
£20 million
Agency or Funder
UK Research and Innovation & National Institute for Health Research (NIHR)
Eligibility (if available)

UK academia, industry experts and international partners

Foreign participation? (where known)
Yes
Date application deadline

Rapid Response Call for "Active intervention development" and "Diagnosing and understanding COVID-19"

Date added: 23 Apr 2020

Research is to focus on vaccines and therapeutics; and on diagnostics, clinical investigations, anthropology investigations, and development of technologies, platforms or systems to accelerate the R&D of diagnostics.

Amount
£20M
Agency or Funder
National Institute for Health Research
Eligibility (if available)

Hosted by a UK institution eligible for UKRI funding. Overseas research organisations in affected countries providing important local engagement can be co-investigators

Foreign participation? (where known)
Yes
Date application deadline

Special Call on Coronaviruses

Date added: 23 Apr 2020

Any aspect of coronavirus research. Applicants may request up to 300,000 francs for projects lasting up to 24 months. Bigger grants are conceivable, provided the applicant has good reasons for requesting a higher amount.

Amount
CHF 5M
Agency or Funder
Swiss Nation Science Foundation
Foreign participation? (where known)
Yes
Date application deadline

COVID-19 diagnostic kit development in Uruguay

Date added: 11 May 2020

Funding for private and public institutions that can develop a COVID-19 diagnostics kit for Uruguay by May 2020.

Amount
Up to UYU 6M up to 80% of the costs
Agency or Funder
Uruguay's National Agency for Research and Innovation and the Inter-American Development Bank
Eligibility (if available)

Private companies and research institutions

Date application deadline

IRHPA COVID 2020 Call

Date added: 23 Apr 2020

A special call specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.

Amount
Not specified
Agency or Funder
Science & Engineering Research Board, India
Eligibility (if available)

One of the participating institutions should have access to Biosafety Level 3 and above facilities, along with expertise of handling respiratory viruses as per WHO/Govt. of India protocols.

Foreign participation? (where known)
No
Date application deadline

Support for vaccines, therapeutics and diagnostics that are scalable and have commercial potential – explicitly not a research fellowship: CLOSED

Date added: 23 Apr 2020

A call for proposals to accelerate development of diagnostics, vaccines, novel therapeutics and re-purposing of drugs

Amount
Budget depends on the proposed activities
Agency or Funder
Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC)
Eligibility (if available)

SMEs, Limited liability Partnership (LLP), Public or Private Research Institute, University and Non-academic Individuals.

Foreign participation? (where known)
No
Date application deadline

IMI2 - Call 21

Date added: 23 Apr 2020

Development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak; therapeutics to address the current and/or future coronavirus outbreaks; diagnostics, ensuring rapid evaluation of candi

Amount
€45M
Agency or Funder
IMI
Eligibility (if available)

See funding call for eligibility rules

Date application deadline

With the support of the World Bank, funding for applied research and commercialisation

Date added: 23 Apr 2020

Funding for universities, technologists and researchers with innovative proposals, including seed funding, to provide solutions applicapel to the COVID-19 pandemic.

Amount
Rs. 15M max.
Agency or Funder
Higher Education Commission & World Bank
Eligibility (if available)

Universities, technologists, researchers

Foreign participation? (where known)
No
Date application deadline